Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

No definitive link between finasteride and male breast cancer, but further research is needed.

Certain spices may help prevent and treat skin cancer, but more human trials are needed.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

The document concludes that modern photo stories help represent and challenge how breast cancer affects women's identities and societal norms.

Mohs micrographic surgery is effective for early-stage non-melanoma skin cancers on the lips, with basal cell carcinoma more common on the upper cutaneous lip and squamous cell carcinoma more common on the lower vermilion lip.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Cyclosporin doesn't stop hair loss.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Core symptoms in breast cancer chemotherapy remain stable, aiding targeted interventions.

Men with melanoma have a higher risk of later being diagnosed with prostate cancer.

Athletes need effective management of skin disorders for their performance and well-being.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

New markers can detect tumors, aid drug delivery, and treat cancer effectively and safely.

African plants may help treat cancer by boosting immunity and protecting cells.